Ashland and Safic-Alcan have been building a strategic business relationship focused on life sciences markets in Spain and Portugal. We now look forward to extending our strategic collaboration with Safic-Alcan in Germany to deliver premium service to our customers in the region.
Safic-Alcan extends strategic collaboration with Ashland in the DACH region
Paris, La Defense, April 2nd, 2024–Safic-Alcan announces the extension of its strategic collaboration and distribution agreement with Ashland, a global leader in additives and specialty ingredients. This partnership will cover Ashland's pharmaceutical and nutraceutical ingredients portfolio in the DACH region, covering Germany, Austria and Switzerland, starting from July 1st, 2024.
This collaborative endeavour between Ashland and Safic-Alcan is dedicated to delivering top-notch pharmaceutical solutions, featuring renowned products such as Plasdone™ povidone, Polyplasdone™ crospovidone, Klucel™ hydroxypropylcellulose, Benecel™ hydroxypropylmethylcellulose, Natrosol™ hydroxyethylcellulose.
Marc Freimuth, Technical Sales Manager for Pharma & Nutra at Safic-Alcan Deutschland GmbH, emphasized Ashland's significance affirming "Ashland will be our Nᵒ 1 Supplier and an important Pillar of Pharma in Safic-Alcan Germany!"
Tomas Navarro, Ashland's General Manager for Life Sciences in EMEA, expressed his views on the collaboration, stating
"Our continued partnership with Ashland signifies a commitment to excellence and innovation," remarked Jose Lora, Life Sciences Managing Director at Safic-Alcan. “With a successful track record in Iberia as Ashland's long-standing distributor, we are elated to expand this strategic collaboration to the vibrant pharmaceutical landscape of the DACH region."
Further elaborating on this exciting venture, Gaël Garnaud, Pharmaceuticals and Animal Nutrition Business Development Director at Safic Alcan, added, "The DACH region represents a significant market for us, and we are dedicated to optimizing it. Our emphasis lies in nurturing our customer relationships while leveraging the cutting-edge technology Ashland provides. This milestone partnership reflects the evolution of our longstanding association with Ashland, underlining our joint pursuit of advancement and customer satisfaction."
As industry leaders in their respective domains, Safic-Alcan and Ashland are poised to set new standards in the pharmaceutical sector. With a steadfast commitment to innovation and client-centric solutions, this strategic collaboration is set to redefine the future of pharmaceutical and nutraceutical ingredient distribution in the DACH region and beyond.
About Safic-Alcan
Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals, and nutraceuticals industries. With a network of 35 offices strategically located in Europe, Turkey, Middle East, North America, Mexico, South America, China and South Africa, and 780 people worldwide, Safic-Alcan generated a turnover of 907 M€ in 2022. Learn More
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 3,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Learn more.
